Intralesional injection of vitamin D3 versus zinc sulfate 2% in treatment of plantar warts: a comparative study.
Conclusion: Intralesional Vit. D3 and Zinc sulfate appear to be effective treatment modalities for plantar warts. PMID: 31415213 [PubMed - as supplied by publisher]
Human papillomavirus type-6 (HPV6) is the major etiological agent of anogenital warts both men and women. The present study aimed to characterize the genetic diversity among HPV6 in Southwest China, and to inv...
Conclusions: MBL play an important role in host defense against HPV infection. PMID: 31469597 [PubMed - as supplied by publisher]
Human papillomavirus (HPV) presents tropism for the skin and mucous membranes and produces a variety of afflictions. There are available many studies on the role of oxidative stress in HPV-associated cervical cancer; however data on cutaneous lesions is scarce. In recent years, it has been highlighted that lipid peroxidation is an important step in the pathogenesis of many diseases. We have enrolled 26 patients with palmoplantar warts, 15 patients with genital warts and 28 healthy subjects. To determine the level of lipid peroxidation we have measured the serum levels of 4-hydroxynonenal (4-HNE) by ELISA method.
Genital human papilloma virus (HPV) infection is the most common sexually transmitted infection. It may be asymptomatic or manifests as benign or malignant lesions. The pathogenesis of HPV infection is not completely elucidated; in most cases spontaneous viral clearance occurs. In our study we have investigated the effect of HPV infection on the balance between oxidants and antioxidants in patients with genital warts. We have determined the serum levels of soluble receptor for advanced glycation end products (sRAGE), total oxidant status (TAS) and total antioxidant status (TOS) in 15 patients with genital warts and 28 healthy subjects.
AbstractIn the U.S. there is an epidemic of sexually transmitted diseases (STIs). One of the most prevalent STIs is the Human Papillomavirus (HPV). Certain high risk strains of HPV are believed to cause virtually all cervical cancers, over 90% of anal cancers, 70% of oropharyngeal cancers, and the majority of anal genital warts. HPV is preventable through vaccination and is available for both men and women. Several educational interventions have been employed, yet baseline awareness and knowledge related to HPV and 9vHPV remains relatively low among young men. What is not known is the most effective method for provid...
Abstract Human papillomavirus (HPV) causes nearly all cervical cancers and some cancers of the vagina, vulva, penis, anus, and oropharynx (1).* Most HPV infections are asymptomatic and clear spontaneously within 1 to 2 years; however, persistent infection with oncogenic HPV types can lead to development of precancer or cancer (2). In the United States, the 9-valent HPV vaccine (9vHPV) is available to protect against oncogenic HPV types 16, 18, 31, 33, 45, 52, and 58 as well as nononcogenic types 6 and 11 that cause genital warts. CDC analyzed data from the U.S. Cancer Statistics (USCS)† to assess the incide...
Background: Verruca vulgaris (common warts) is a cutaneous manifestation of the human papillomavirus that impacts children and adults. Effective treatment is challenging as no FDA-approved therapies are available. We evaluated the efficacy and safety of the proprietary, stabilized hydrogen peroxide topical solution, 45% (w/w) (HP45) in patients with common warts.
Background: Verruca vulgaris (common warts) is a cutaneous manifestation of the human papillomavirus with no FDA-approved therapies available. We evaluated the long-term efficacy and safety of the proprietary, stabilized hydrogen peroxide topical solution, 45% (w/w) (HP45) in patients with common warts at 12 weeks after treatment completion.
Background: Common warts (Verruca vulgaris) are benign, contagious, cutaneous manifestations of the human papillomavirus. A proprietary, stabilized hydrogen peroxide topical solution, 45% (w/w) (HP45) is in clinical development for treatment of common warts. The Physician Wart AssessmentTM (PWA) is a clinician-rated 4-ordinal scale (0, clear/no treatment indicated; 1, near clear/visible wart
This article is protected by copyright. All rights reserved. PMID: 31434164 [PubMed - as supplied by publisher]